ProCE Banner Activity

CCO 2021 Global Conference Coverage: Gynecologic Cancer Updates

Slideset Download
Conference Coverage

Download this “living” summary slideset covering new data from key studies in gynecologic cancers as they are presented at different conferences throughout 2021.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Released: November 15, 2021

Expiration: November 14, 2022

Share

Faculty

Jubilee Brown

Jubilee Brown, MD

Professor and Division Director
Gynecologic Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Nicole Concin

Nicole Concin, MD, PhD

Professor
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Innsbruck, Austria
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
Essen, Germany

Bernard Doger de Spéville

Bernard Doger de Spéville, MD, PhD

Medical Oncology
START-Madrid, Early Phase Clinical Trials Unit
Hospital Fundación Jiménez Diaz
Madrid, Spain

Alexandra Leary

Alexandra Leary, MD, PhD

Co-Director, Department of Medical Oncology
Medical Oncologist, Gynecology
Team Leader, Gynecologic Translational Research Lab
Institut Gustave Roussy
Paris, France

Domenica Lorusso

Domenica Lorusso, MD, PhD, Prof

Full Professor of Obstetrics and Gynecology
Humanitas University
Head of Gynecology Oncology Medical Unit
Humanitas Hospital San Pio X
Milan, Italy

Ursula Matulonis

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology
Brock-Wilson Faculty Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Prof Isabelle Ray-Coquard

Prof Isabelle Ray-Coquard, MD, PhD

President of the Gineco Group
Centre Leon Bérard
Laboratoire RESHAPE u1290
Université Claude Bernard Lyon Est
Lyon, France

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Jubilee Brown, MD

Professor and Division Director
Gynecologic Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Nicole Concin, MD, PhD

Professor
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Innsbruck, Austria
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
Essen, Germany

Prof Nicole Concin, MD, PhD, has disclosed that she has received consulting fees from Akesobio, AstraZeneca, Eisai, eTheRNA, GlaxoSmithKline, Mersana, and Seagen; and fees for non-CME/CE services from Amgen, Genmab, MSD, and Roche.

Bernard Doger de Spéville, MD, PhD

Medical Oncology
START-Madrid, Early Phase Clinical Trials Unit
Hospital Fundación Jiménez Diaz
Madrid, Spain

Bernard Doger de Spéville, MD, PhD, has no conflict of interest to disclose.

Alexandra Leary, MD, PhD

Co-Director, Department of Medical Oncology
Medical Oncologist, Gynecology
Team Leader, Gynecologic Translational Research Lab
Institut Gustave Roussy
Paris, France

Alexandra Leary, MD, PhD, has disclosed that she has received consulting fees from Ability, AstraZeneca, Biocad, Clovis, GlaxoSmithKline, Merck Serono, MSD, Seagen, Tesaro and Zentalis; other financial or material support from AstraZeneca, Clovis, GlaxoSmithKline, and Tesaro; and funds for research support from Ability, AstraZeneca, Clovis, GlaxoSmithKline, MSD, and Tesaro.

Domenica Lorusso, MD, PhD, Prof

Full Professor of Obstetrics and Gynecology
Humanitas University
Head of Gynecology Oncology Medical Unit
Humanitas Hospital San Pio X
Milan, Italy

Domenica Lorusso, MD, PhD, has disclosed that she has received consulting fees from Amgen, AstraZeneca, Clovis, GlaxoSmithKline, MSD, and Pharmamar; fees for non-CME/CE services from MSD; and other financial or material support from AstraZeneca, Clovis, GlaxoSmithKline, and Pharmamar.

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology
Brock-Wilson Faculty Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Prof Isabelle Ray-Coquard, MD, PhD

President of the Gineco Group
Centre Leon Bérard
Laboratoire RESHAPE u1290
Université Claude Bernard Lyon Est
Lyon, France

Isabelle Ray-Coquard, MD, PhD, has disclosed that she has received consulting fees from Amgen, AstraZeneca, Clovis, Deciphera, GlaxoSmithKline, Mersana, MSD, and Roche.